30-Jul-2014 - Amgen is slashing 15% of its workforce and closing two US manufacturing facilities as part of a restructure the firm says will save $700m (€520m) a year.
29-Jul-2014 - Robust quality systems differentiate Biocon from other Indian manufacturers, the firm says, despite political turmoil in the Middle East and North Africa impacting first quarter 2015 sales.
29-Jul-2014 - Analytic science company Waters has acquired all of the assets of MediMass, which includes its Rapid Evaporative Ionization Mass Spectrometry (REIMS) technology, as well as patent applications, software, databases and REIMS expertise.
23-Jul-2014 - Patent expiration and a large molecule pipeline has prompted Eli Lilly to repurpose a solid oral dose plant in Indiana.
22-Jul-2014 - Botox maker Allergan announced sales and earnings per share growth above the high end of its expectations, but it will cut 1,500 jobs, or about 13% of its workforce as it continues to avoid a $54bn hostile takeover bid from Valeant Pharmaceuticals.
21-Jul-2014 - India-based Glenmark Pharmaceuticals has announced plans to set up a new oral solid dosage manufacturing facility in North Carolina.
15-Jul-2014 - Biocatalyst developer Codexis says its new platform licensing deal with GSK is a model with which it can approach other Big Pharma firms.
11-Jul-2014 - Pfizer says 100 workers at an Irish facility will now keep their jobs due to an unpredicted increase in production volumes of off-patent drugs.
10-Jul-2014 - Actavis says it is closing facilities in St. Louis, Missouri affecting 190 jobs a week after completing the $28bn (€21bn) acquisition of Forest Laboratories.
10-Jul-2014 - G-CON says a multi-million dollar investment by Pfizer could hasten the “paradigm shift” in pharma manufacturing towards flexible cleanroom technology and portable facility design.
08-Jul-2014 - Finished dosage form and API manufacturer Xellia has acquired a US plant from Fresenius Kabi in a deal it says enhances supply chain security.
08-Jul-2014 - M+W says a lack of synergies with its engineering and construction business drove the decision to sell its automation divison to ATS for €255m ($348m).
01-Jul-2014 - With its purchase of Veropharm for up to $495m, Abbott is looking to tap into one of the largest Russian manufacturers of pharmaceuticals.
30-Jun-2014 - Chinese pharma is looking for added value and “famous brands” from its processing providers, the tableting and packaging supplier Romaco has said.
25-Jun-2014 - The United States Food and Drug Administration (FDA) has announced it will consider products outside the nanoscale, up to 1,000 nanometres (nm), to involve nanotechnology and so be potentially liable for “particular examination.”
24-Jun-2014 - BioReliance and its parent company SAFC say they are working on viral-resistant cell lines that will prevent contamination in bioreactors.
23-Jun-2014 - The US National Institutes of Health (NIH) has launched a 3D Print Exchange which will turn data submitted by the public into files for printing 3D models.
17-Jun-2014 - Fette Compacting America claims its new tablet press technology can accelerate the production of large drug batches.
12-Jun-2014 - Teva could halve its manufacturing network as part of its $2bn-a-year efficiency programme says CFO Eyal Desheh, with most cuts hitting its core generics business.
10-Jun-2014 - Malvern Instruments will buy GE Healthcare’s MicroCal business in a deal that adds protein analysis and formulation development tech to its expanding drug industry offering.
09-Jun-2014 - J&J says it collaborated with Novartis and GSK to install wind turbines in Cork, Ireland to substantially reduce electricity costs at its local manufacturing plants.
05-Jun-2014 - The Puerto Rico Industrial Development Company (PRIDCO) says Actavis’ investment at two facilities is evidence of continued pharma growth, despite a number of recent closures on the island.
05-Jun-2014 - The days of testing for leaks in blister packs with traditional blue dye are numbered at Pfizer, which has replaced the method with high-tech scans.
03-Jun-2014 - Tax breaks and the promise of preferential treament for locally made drugs were key to attracting Pfizer to the UAE says DuBiotech.
29-May-2014 - Hikma Pharmaceuticals says it is evaluating Ben Venue’s manufacturing facility as an option in its $300m (€220m) acquisition of Bedford Laboratories.
G-CON says a multi-million dollar investment by Pfizer could hasten the “paradigm shift” in pharma manufacturing towards...
Indian drugmakers must invest heavily in compliance processes in response to the US FDA’s “aggressive surveillance” and...
The current model of antibiotic development “is broken,” says the Professor of Pharmaceutical Innovation at Kings College,...
Zogenix has modified its much-debated painkiller Zohydro with abuse-deterrent formulations.
The US FDA approved Afrezza last weekend after deeming that the inhaled insulin drug and the dry...